Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Explore effective wise investment strategies that can help you achieve long-term gains. Learn how to grow your wealth sustainably.
27,808 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Oil and currency markets tremble as new Iran-related tensions top the global agenda. Asia, with its export-led growth...
Shares surged after quarterly results, lifting the outlook for this dividend-paying chip stock. Analysts say the stoc...
Britain’s top spy says the window to outpace adversaries is shrinking, pushing cybersecurity to the forefront of pers...
JPMorgan argues the macro bet that fueled Bitcoin gains is cooling, with BTC near $63,000 as markets digest easing te...
A Solvang, California property once linked to Dolly Parton is back on the market for about $2 million, boasting a win...
Stellar leads in on-chain real-world asset tokenization, but XRP still dominates in price. The divergence spotlights ...
Beaten-down brands aren’t a bet on luck—they’re a test of resilience. This piece explores two stocks down right hold ...
Trump's remarks on a major U.S. refinery milestone vault the energy complex into the spotlight, with Marathon Petrole...
A new wave of questions surrounds a16z exec steven sinofsky as reports tie him to Epstein during his Microsoft exit. ...
As geopolitical tensions flare and oil costs surge, recession odds jump higher. Moody's Analytics now grids a near-50...
Trump Media posted a $405.9 million quarterly loss in Q1 2026, largely tied to unrealized cryptocurrency holdings, ev...